Kazazian Asset Management, LLC Bridge Bio Pharma, Inc. Transaction History
Kazazian Asset Management, LLC
- $131 Billion
- Q4 2024
A detailed history of Kazazian Asset Management, LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Kazazian Asset Management, LLC holds 13,520 shares of BBIO stock, worth $420,742. This represents 0.28% of its overall portfolio holdings.
Number of Shares
13,520Holding current value
$420,742% of portfolio
0.28%Shares
1 transactions
Others Institutions Holding BBIO
# of Institutions
299Shares Held
172MCall Options Held
10.4MPut Options Held
2.33M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$786 Million35.94% of portfolio
-
Viking Global Investors LP25.1MShares$782 Million2.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.1MShares$469 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$387 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$189 Million63.58% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $4.61B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...